PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026European Urology Oncology2 citationsOpen Access

Unveiling the Clinical Potential of Prostate Cancer Three-dimensional Models: A Systematic Review

View Full Paper
APArthur PeyrottesNBNorbert De BrekAAAnne-Sophie Vieira Aleixo

Key Points

  • This research aims to explore the potential of prostate cancer 3D models for studying tumor biology and drug responses.
  • Conducted a systematic review of existing literature on prostate cancer 3D models.
  • Focused on the application of these models in understanding tumor biology and predicting treatment outcomes.
  • Evaluated challenges related to standardization and scalability.
  • Prostate cancer 3D models can effectively predict drug responses.
  • Identified organoids as viable candidates for precision oncology.
  • Noted significant challenges in standardization that need addressing for broader application.

Abstract

Prostate cancer 3D models offer a relevant, patient-specific platform to study tumor biology, predict drug responses, and identify novel biomarkers. While standardization and scalability challenges persist, organoids have a strong potential for integration into precision oncology pipelines.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Peyrottes et al. (2026) studied this question.

synapsesocial.com/papers/69d1fc28a79560c99a0a1c5ahttps://doi.org/10.1016/j.euo.2026.03.007
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Anti-Cancer Properties of Two Intravenously Administrable Curcumin Formulations as Evaluated in the 3D Patient-Derived Cancer Spheroid Model2024 · 3 citations
  2. 2Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase2023 · 17 citations
  3. 3SYRCLE’s risk of bias tool for animal studies2014 · 4,325 citations
  4. 4Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening2014 · 94 citations
  5. 5DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer2024 · 19 citations